Showing 5 of 5 recruiting trials for “asherman-syndrome”
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT05984394 ↗
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
RecruitingNCT05989399 ↗
Evaluation of Circulating Neutrophils in Antisynthetase Syndrome
RecruitingNCT04507997 ↗
Angelman Syndrome Natural History Study
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →